請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37309完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 胡忠怡 | |
| dc.contributor.author | Cheng-Ju Chan | en |
| dc.contributor.author | 詹承儒 | zh_TW |
| dc.date.accessioned | 2021-06-13T15:24:02Z | - |
| dc.date.available | 2009-08-08 | |
| dc.date.copyright | 2008-08-08 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-22 | |
| dc.identifier.citation | References
1. Hahn, B. H. (2005) Systemic Lupus Erythematosus, in Harrison's principle of internal medicine (Kasper, D. L., Fauci, A. S., Longo, D. L., Braunwald, E., Hauser, S. L., and Jameson, J. L., Eds.) 16 ed., pp 1960-1968, McGraw-Hill. 2. Croker, J. A. and Kimberly, R. P. (2005) SLE: challenges and candidates in human disease. Trends Immunol. 26, 580-586. 3. Lu, J. J., Chen, D. Y., Hsieh, C. W., Lan, J. L., Lin, F. J., and Lin, S. H. (2007) Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 16, 168-175. 4. Graham, R. R., Ortmann, W. A., Langefeld, C. D., Jawaheer, D., Selby, S. A., Rodine, P. R., Baechler, E. C., Rohlf, K. E., Shark, K. B., Espe, K. J., Green, L. E., Nair, R. P., Stuart, P. E., Elder, J. T., King, R. A., Moser, K. L., Gaffney, P. M., Bugawan, T. L., Erlich, H. A., Rich, S. S., Gregersen, P. K., and Behrens, T. W. (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71, 543-553. 5. Chen, J. Y., Wang, C. M., Ma, C. C., Luo, S. F., Edberg, J. C., Kimberly, R. P., and Wu, J. (2006) Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients. Arthritis Rheum. 54, 3908-3917. 6. Krishnan, S. and Tsokos, G. C. (2006) Systemic Lupus Erythematosus: New Ideas for Diagnosis and Treatment, in Immunogenomics and Human Disease (Falus, A., Ed.) pp 249-270, John Wiley. 7. Ravichandran, K. S. and Lorenz, U. (2007) Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol. 7, 964-974. 8. Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., and Girkontaite, I. (1997) Immunosuppressive effects of apoptotic cells. Nature 390, 350-351. 9. Kim, S., Elkon, K. B., and Ma, X. (2004) Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity. 21, 643-653. 10. Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., and Nagata, S. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304, 1147-1150. 11. Asano, K., Miwa, M., Miwa, K., Hanayama, R., Nagase, H., Nagata, S., and Tanaka, M. (2004) Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200, 459-467. 12. Cohen, P. L., Caricchio, R., Abraham, V., Camenisch, T. D., Jennette, J. C., Roubey, R. A., Earp, H. S., Matsushima, G., and Reap, E. A. (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196, 135-140. 13. Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., and Matsushima, G. K. (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207-211. 14. Mevorach, D., Zhou, J. L., Song, X., and Elkon, K. B. (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188, 387-392. 15. Baumann, I., Kolowos, W., Voll, R. E., Manger, B., Gaipl, U., Neuhuber, W. L., Kirchner, T., Kalden, J. R., and Herrmann, M. (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46, 191-201. 16. Schneider, C., King, R. M., and Philipson, L. (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54, 787-793. 17. Manfioletti, G., Brancolini, C., Avanzi, G., and Schneider, C. (1993) The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell Biol. 13, 4976-4985. 18. Karl, M. O., Kroeger, W., Wimmers, S., Milenkovic, V. M., Valtink, M., Engelmann, K., and Strauss, O. (2008) Endogenous Gas6 and Ca2+ -channel activation modulate phagocytosis by retinal pigment epithelium. Cell Signal. 20, 1159-1168. 19. ngelillo-Scherrer, A., de, F. P., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M., Herbert, J., Collen, D., Dahlback, B., and Carmeliet, P. (2001) Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat. Med. 7, 215-221. 20. Balogh, I., Hafizi, S., Stenhoff, J., Hansson, K., and Dahlback, B. (2005) Analysis of Gas6 in human platelets and plasma. Arterioscler. Thromb. Vasc. Biol. 25, 1280-1286. 21. Saccone, S., Marcandalli, P., Gostissa, M., Schneider, C., and Della, V. G. (1995) Assignment of the human GAS6 gene to chromosome 13q34 by fluorescence in situ hybridization. Genomics 30, 129-131. 22. Marcandalli, P., Gostissa, M., Varnum, B., Goruppi, S., and Schneider, C. (1997) Identification and tissue expression of a splice variant for the growth arrest-specific gene gas6. FEBS Lett. 415, 56-58. 23. Varnum, B. C., Young, C., Elliott, G., Garcia, A., Bartley, T. D., Fridell, Y. W., Hunt, R. W., Trail, G., Clogston, C., Toso, R. J., and . (1995) Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 373, 623-626. 24. Ohashi, K., Nagata, K., Toshima, J., Nakano, T., Arita, H., Tsuda, H., Suzuki, K., and Mizuno, K. (1995) Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. J. Biol. Chem. 270, 22681-22684. 25. Chen, J., Carey, K., and Godowski, P. J. (1997) Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 14, 2033-2039. 26. Graham, D. K., Dawson, T. L., Mullaney, D. L., Snodgrass, H. R., and Earp, H. S. (1994) Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ. 5, 647-657. 27. O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., Prokop, C., Espinosa, R., III, Le Beau, M. M., Earp, H. S., and Liu, E. T. (1991) axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell Biol. 11, 5016-5031. 28. Mark, M. R., Scadden, D. T., Wang, Z., Gu, Q., Goddard, A., and Godowski, P. J. (1994) rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. J. Biol. Chem. 269, 10720-10728. 29. Sasaki, T., Knyazev, P. G., Clout, N. J., Cheburkin, Y., Gohring, W., Ullrich, A., Timpl, R., and Hohenester, E. (2006) Structural basis for Gas6-Axl signalling. EMBO J. 25, 80-87. 30. Goruppi, S., Ruaro, E., Varnum, B., and Schneider, C. (1999) Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene 18, 4224-4236. 31. ngelillo-Scherrer, A., Burnier, L., Flores, N., Savi, P., DeMol, M., Schaeffer, P., Herbert, J. M., Lemke, G., Goff, S. P., Matsushima, G. K., Earp, H. S., Vesin, C., Hoylaerts, M. F., Plaisance, S., Collen, D., Conway, E. M., Wehrle-Haller, B., and Carmeliet, P. (2005) Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J. Clin. Invest 115, 237-246. 32. Wu, Y., Singh, S., Georgescu, M. M., and Birge, R. B. (2005) A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J. Cell Sci. 118, 539-553. 33. Costa, M., Bellosta, P., and Basilico, C. (1996) Cleavage and release of a soluble form of the receptor tyrosine kinase ARK in vitro and in vivo. J. Cell Physiol 168, 737-744. 34. Budagian, V., Bulanova, E., Orinska, Z., Duitman, E., Brandt, K., Ludwig, A., Hartmann, D., Lemke, G., Saftig, P., and Bulfone-Paus, S. (2005) Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol. Cell Biol. 25, 9324-9339. 35. Sather, S., Kenyon, K. D., Lefkowitz, J. B., Liang, X., Varnum, B. C., Henson, P. M., and Graham, D. K. (2007) A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 109, 1026-1033. 36. ngelillo-Scherrer, A., Burnier, L., Lambrechts, D., Fish, R. J., Tjwa, M., Plaisance, S., Sugamele, R., DeMol, M., Martinez-Soria, E., Maxwell, P. H., Lemke, G., Goff, S. P., Matsushima, G. K., Earp, H. S., Chanson, M., Collen, D., Izui, S., Schapira, M., Conway, E. M., and Carmeliet, P. (2008) Role of Gas6 in erythropoiesis and anemia in mice. J. Clin. Invest 118, 583-596. 37. Munoz, X., Sumoy, L., Ramirez-Lorca, R., Villar, J., de Frutos, P. G., and Sala, N. (2004) Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Hum. Mutat. 23, 506-512. 38. Munoz, X., Obach, V., Hurtado, B., de Frutos, P. G., Chamorro, A., and Sala, N. (2007) Association of specific haplotypes of GAS6 gene with stroke. Thromb. Haemost. 98, 406-412. 39. Munoz, L. E., van, B. C., Franz, S., Berden, J., Herrmann, M., and van, d., V (2008) Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17, 371-375. 40. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., and Walport, M. J. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56-59. 41. Tjwa, M., Bellido-Martin, L., Lin, Y., Lutgens, E., Plaisance, S., Bono, F., esque-Touchard, N., Herve, C., Moura, R., Billiau, A. D., Aparicio, C., Levi, M., Daemen, M., Dewerchin, M., Lupu, F., Arnout, J., Herbert, J. M., Waer, M., Garcia de, F. P., Dahlback, B., Carmeliet, P., Hoylaerts, M. F., and Moons, L. (2008) Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 111, 4096-4105. 42. Yamaguchi, H., Takagi, J., Miyamae, T., Yokota, S., Fujimoto, T., Nakamura, S., Ohshima, S., Naka, T., and Nagata, S. (2008) Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus. J. Leukoc. Biol. 83, 1300-1307. 43. Nagai, K., Arai, H., Yanagita, M., Matsubara, T., Kanamori, H., Nakano, T., Iehara, N., Fukatsu, A., Kita, T., and Doi, T. (2003) Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 278, 18229-18234. 44. Fiebeler, A., Park, J. K., Muller, D. N., Lindschau, C., Mengel, M., Merkel, S., Banas, B., Luft, F. C., and Haller, H. (2004) Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am. J. Kidney Dis. 43, 286-295. 45. Song, K. S., Park, Y. S., and Kim, H. K. (2000) Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 43, 557-560. 46. Guermazi, S., Regnault, V., Gorgi, Y., Ayed, K., Lecompte, T., and Dellagi, K. (2000) Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus. Blood Coagul. Fibrinolysis 11, 491-498. 47. Anderson, H. A., Maylock, C. A., Williams, J. A., Paweletz, C. P., Shu, H., and Shacter, E. (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 4, 87-91. 48. Nagata, K., Ohashi, K., Nakano, T., Arita, H., Zong, C., Hanafusa, H., and Mizuno, K. (1996) Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J. Biol. Chem. 271, 30022-30027. 49. Kask, L., Trouw, L. A., Dahlback, B., and Blom, A. M. (2004) The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J. Biol. Chem. 279, 23869-23873. 50. Uehara, H. and Shacter, E. (2008) Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J. Immunol. 180, 2522-2530. 51. Lu, Q. and Lemke, G. (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293, 306-311. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37309 | - |
| dc.description.abstract | 生長停滯特異性基因6(Gas6)產物屬於vitamin K-dependent蛋白家族之一員，為一廣泛表現於人體內多種組織細胞(如內皮細胞、巨噬細胞、肺臟、小腸與骨髓等)之分泌性蛋白。Gas6蛋白之N端可與凋亡細胞表面之phosphatidylserine (PtdSer)結合，C端可為吞噬細胞表面的Gas6之接受器Mer所辨識，故Gas6於吞噬過程中具有橋接分子之功能。全身性紅斑性狼瘡(SLE)是一種系統性、慢性發炎的自體免疫疾病，起因於病人體內存在有會對抗自身抗原的淋巴球、自體抗體以及免疫複合物。在小鼠模型中發現，清除凋亡細胞之過程若有缺陷，會增加自體抗原暴露之機會，因而與自體免疫疾病(如SLE)之發生相關，本研究即希望探討橋接分子Gas6之異常表現與人類SLE發生或疾病進展之可能關聯。
本研究針對83名全身性紅斑性狼瘡病人以及40名非狼瘡對照組進行血清Gas6含量以及Gas6基因單點核甘酸變異之基因型分析。結果顯示40.96%的SLE病患相較於非狼瘡對照組有較高的血清Gas6含量(SLE: 24.51±14.06ng/mL, non-lupus control: 18.44±6.29 ng/mL, p<0.0001)，進一步分析血清Gas6量與發炎指標ESR、CRP之關聯，初步認定與發炎關聯不大。此外在高疾病活性(SLEDAI>6)、有狼瘡性腎炎或有血管炎之SLE病患均比其他SLE病患有較高的血清Gas6含量(高SLEDAI組: 25.65±14.77ng/mL, 低SLEDAI組: 20.89±8.70ng/mL, p=0.0092；有腎炎組: 27.40±14.70ng/mL, 無腎炎組: 23.52±13.51ng/mL, p=0.0286；有血管炎組: 28.55±14.54ng/mL, 無血管炎組: 23.71±13.69ng/mL, p=0.0287)。本研究亦分析Gas6基因intronic單點核苷酸變異(SNP)834+7G/A與同義性SNP1332C/T。基因分型結果顯示，Gas6 834+7A對偶基因型與SLE病患發生血小板減少有正相關(odds ratio=3.05, 95% CI: 1.02-9.13, p= 0.047)，而Gas6 1332之T對偶基因與SLE病患發生血管炎有正相關(odds ratio=3.07, 95% CI: 1.25-7.56, p=0.013)。此外帶Gas6 834+7GA/AA基因型的SLE病患血清中Gas6含量較帶Gas6 834+7GG基因型的SLE病患高(834+7GA/AA group: 27.03±16.44ng/mL, 834+7GG: 22.94±11.43ng/mL, p=0.0168)。結論：1. 相較於非狼瘡對照組，SLE病患血清Gas6量較高，且並非全由發炎造成，血清中較高的Gas6量可能與SLE的發生或疾病進展有關。2. 有腎炎與血管炎的SLE病患有較高的血清Gas6量。3. Gas6 SNP 1332C/T 與834+7G/A基因型分別與SLE病患血管炎、血小板減少有正相關。 | zh_TW |
| dc.description.abstract | Growth arrest specific gene 6, a member of vitamin K-dependent protein family, is expressed in endothelial cells, macrophage, lung, intestine and bone marrow in a secreted form. Gas6 can function as bridging molecule between phosphatidylserine (PtdSer) on the apoptotic cells and Mer receptor on macrophages.Systemic lupus erythematosus(SLE) is an autoimmune disease characterized by chronic systemic inflammation resulted from autoreactive lymphocytes, autoantibodies and immune complexes. Ineffective clearance of apoptotic cells which leads to the release of self-antigen, may be important in the development of lupus-like autoimmune disease in mice. In this study, we intend to investigate whether serum Gas6 level and genetic variation in Gas6 are associated with prevalence or disease activity of human SLE.
Seral Gas6 level and the single nucleotide polymorphisms (SNPs) on Gas6 gene were investigated in 83 SLE patients and 40 non-lupus control subjects. Elevated serum Gas6 level was noted in 40.96% of SLE patients as compared with the non-lupus control.(SLE: 24.51±14.06ng/mL versus non-lupus control: 18.44±6.29 ng/mL, p≦0.0001). Correlation between serum Gas6 and ESR/CRP was also analysed. Serum Gas6 level is unlikely to be associated with inflammatory states in SLE. Furthermore, SLE patients with high disease activity index (SLEDAI>6), lupus nephritis or vasculitis showed higher serum Gas6 level than the other SLE patients. (high SLEDAI group: 25.65±14.77ng/mL versus low SLEDAI group: 20.89±8.70ng/mL, p=0.0092; nephritis group: 27.40±14.70ng/mL versus non-nephritis group: 23.52±13.51ng/mL, p=0.0286; vasculitis group: 28.55±14.54ng/mL versus non-vasculitis group: 23.71±13.69ng/mL, p=0.0287).Two single nucleotide polymorphisms (SNPs), intronic Gas6 834+7G/A and synonymous Gas6 1332C/T were studied. The genotyping results indicate that Gas6 834+7 A allele is positively associated with thrombocytopenia in SLE patients (odds ratio=3.05, 95% CI: 1.02-9.13, p= 0.047) and Gas6 1332 T allele was positively associated with vasculitis in SLE patients (odds ratio=3.07, 95% CI: 1.25-7.56, p=0.013). Furthermore, SLE patients with Gas6 834+7GA/AA genotype showed higher serum Gas6 level as compared to the SLE patients with a GG genotype (834+7GA/AA group: 27.03±16.44ng/mL, 834+7GG: 22.94±11.43ng/mL, p=0.0168). Conclusion: 1. Elevated serum Gas6 level was noted in some of SLE patients and did not completely result from inflammation. Elevated serum Gas6 level may be associated with SLE development. 2. SLE patients with lupus nephritis or vasculitis showed higher serum Gas6 level than the other SLE patients. 3. Gas6 SNP 1332C/T and 834+7G/A are positively associated with vasculitis and thrombocytosis, respectively. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T15:24:02Z (GMT). No. of bitstreams: 1 ntu-97-R95424020-1.pdf: 1933666 bytes, checksum: 970ffcebec0270969f64b18d26c71e28 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 目錄………………………………………………………..………….…….I
中文摘要………………………………………………………………….IV 英文摘要………………………………………………………………….VI 第一章 序論…………………………………………….………………..1 第一節 全身性紅斑性狼瘡簡介…………………..…………………1 壹 自體免疫疾病簡介…………………………………….…….1 貳 全身性紅斑性狼瘡簡介……………………………….…….1 參 全身性紅斑性狼瘡臨床症狀與疾病診斷………………..…2 肆 SLE流行病學資料與可能之罹病風險因子………………..2 第二節 凋亡細胞清除與全身性紅斑性狼瘡之關聯…………..……4 第三節 生長停滯特異性基因6產物與其接受器簡介………...……6 壹 生長停滯特異性基因產物6………………….……………..6 貳 Gas6之接受器---Tyro3 family…………..…………………..7 參 Gas6與吞噬清除功能…………………….…………………9 第四節 研究目的與實驗設計………………….…………………...10 第二章 材料與方法……….……………………………………………11 第一節 材料…………………………………………...…………….11 壹 檢體收集…………………………...……………………….11 貳 試劑清單………………………………...………………….12 參 試劑組/酵素………………………..…………………….…13 肆 聚合酶鏈鎖反應引子………………………………………14 伍 實驗儀器……………………………...…………………….15 陸 軟體與網路工具……………………………………………16 第二節 試劑配方……………………...…………………………….17 第三節 方法………………………………...……………………….20 壹 檢體處理……………………………...…………………….20 貳 Genomic DNA純化……………..………………………….20 參 聚合酶鏈鎖反應……………………...….…………………21 肆 洋菜膠電泳分析…………………………………………....25 伍 PCR產物純化與定序前處理………….…………………...25 陸 限制酶片段長度多型性分析……….……………………...26 柒 酵素結合免疫吸附法………………………………………27 捌 統計分析……………………………………………………28 第三章 實驗結果……………………………………………………….29 第一節 SLE病人臨床資料與疾病活性、發炎程度、症狀分析…..29 第二節 血清中Gas6蛋白量分析…………………………………..30 壹 SLE病人血清Gas6蛋白量顯著高於非狼瘡對照組…..….30 貳 血清Gas6蛋白量與發炎指標之關聯性分析…………..….30 參 血清Gas6蛋白量與SLE疾病活性之關聯性分析……...…31 肆 血清Gas6蛋白量與臨床症狀之關聯性分析…………...…31 第三節 Gas6基因之候選SNPs篩選……………………………….32 第四節 Gas6基因SNPs基因型分析…………….…………………33 第五節 Gas6基因SNPs與血清Gas6蛋白量相關性分析…………35 第四章 討論…………..…………………………...……………………36 參考文獻…………………………………………………………….……41 圖表…………………………………………..…………………………...47 附錄……………………………………………..………………………...65 | |
| dc.language.iso | zh-TW | |
| dc.subject | 全身性紅斑性狼瘡 | zh_TW |
| dc.subject | 多型性 | zh_TW |
| dc.subject | 單點核苷 | zh_TW |
| dc.subject | 血清生長停滯特異性蛋白6含量 | zh_TW |
| dc.subject | 凋亡細胞清除 | zh_TW |
| dc.subject | 生長停滯特異性基因6 | zh_TW |
| dc.subject | single nucleotide polymorphism(SNP) | en |
| dc.subject | systemic lupus erythematosus (SLE) | en |
| dc.subject | Growth arrest specific gene 6(Gas6 gene) | en |
| dc.subject | clearance of apoptotic cells | en |
| dc.subject | serum Gas6 level | en |
| dc.title | 全身性紅斑性狼瘡病患生長停滯特異性基因6(Gas6)血清蛋白含量與基因變異之相關研究 | zh_TW |
| dc.title | Investigating of Serum Gas6 Level and Gas6 genetic variation in systemic lupus erythematosus(SLE) | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 許秉寧,楊雅倩,莊雅惠 | |
| dc.subject.keyword | 全身性紅斑性狼瘡,生長停滯特異性基因6,凋亡細胞清除,血清生長停滯特異性蛋白6含量,單點核苷,多型性, | zh_TW |
| dc.subject.keyword | systemic lupus erythematosus (SLE),Growth arrest specific gene 6(Gas6 gene),clearance of apoptotic cells,serum Gas6 level,single nucleotide polymorphism(SNP), | en |
| dc.relation.page | 73 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-22 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 醫學檢驗暨生物技術學研究所 | zh_TW |
| 顯示於系所單位： | 醫學檢驗暨生物技術學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 1.89 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。